Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly
Source abstract
Abstract
DNA vaccination has tremendous potential for treating or preventing numerous diseases for which traditional vaccines are ineffective but the technique can be limited by low immunogenicity. Current synthetic DNA delivery systems are versatile and safe, but substantially less efficient than viruses. Here, a novel multicomponent supramolecular system involving the preparation of mannose-bearing chitosan oligomers microspheres with entrapping complexes of DNA vaccine and polyethylenimine was developed to mimic many of the beneficial properties of the viruses. After delivery by intramuscular immunization in BALB/c mice, the microspheres induced an enhanced serum antibody responses two orders of magnitude greater than naked DNA vaccine. Additionally, in contrast to naked DNA, the microspheres induced potent cytotoxic T lymphocyte responses at a low dose. Consequently, formulation of DNA vaccines into multicomponent vectors is a powerful means of increasing vaccine potency.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Immunotherapy and Immune Responses · Animal Virus Infections Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. DNA vaccine10.1146/annurev.immunol.15.1.617 ↗
2. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination10.1073/pnas.94.17.9378 ↗
3. Cellular cytotoxic responses induced by DNA vaccination in HIV-1-infected patients10.1016/S0140-6736(97)09440-3 ↗
4. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine10.1126/science.282.5388.476 ↗
5. Reversible covalent attachment of cholesterol to oligodeoxy-ribonucleotides for studies of the mechanisms of their penetration into eukaryotic cells10.1016/0300-9084(93)90022-K ↗
6. Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection10.1089/10430349950016816 ↗
7. Nucleic acid immunization: concepts and techniques associated with third generation vaccines10.1016/S0022-1759(99)00104-0 ↗
8. Key issues in non-viral gene delivery10.1016/S0169-409X(00)00133-2 ↗
9. Cationic microparticles: a potent delivery system for DNA vaccines10.1073/pnas.97.2.811 ↗
10. Chitosan as a novel nasal delivery system for vaccines10.1016/S0169-409X(01)00171-5 ↗
11. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity10.1038/415331a ↗
12. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations10.1016/S0021-9258(17)41980-6 ↗
13. Vaccine entrapment in liposomes10.1006/meth.1999.0841 ↗
14. Gene therapy: trial and tribulations10.1038/35038533 ↗
15. Targeting tumors with non-viral gene delivery systems10.1016/S1359-6446(02)02243-2 ↗
16. Tumor regression by targeted gene delivery to the neovasculature10.1126/science.1070200 ↗
17. Gene vaccination with naked plasmid DNA: mechanism of CTL priming10.1084/jem.184.4.1555 ↗
18. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells10.1073/pnas.93.16.8578 ↗
19. Some chemical and analytical aspects of polysaccharide modifications. 3. Formation of branch-chain, soluble chitosan derivatives10.1021/ma00133a003 ↗
20. Peniston QP. 1975; USP, 3922260.
21. Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability10.1021/bm034094r ↗
22. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA: poly(l-lysine) complexes
23. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo10.1038/ni962 ↗
24. Purification and characterization of hepatitis B virus surface antigen particles produced in Drosophila Schneider-2 cells10.1016/S0166-0934(99)00022-1 ↗
25. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha10.1053/jhep.2001.21147 ↗
26. Vaccines against intracellular infections requiring cellular immunity10.1038/35021239 ↗
27. Remarkably size-regulated cell invasion by artificial viruses. Saccharide-dependent self-aggregation of glycoviruses and its consequences in glycoviral gene delivery10.1021/ja035636f ↗
28. Targeted gene delivery to cancer cells: directed assembly of nanometric DNA particles coated with folic acid10.1002/anie.200250446 ↗
29. Synthetic DNA delivery systems10.1038/71889 ↗
30. The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer10.1016/j.biomaterials.2004.07.008 ↗
31. Biodegradation and distribution of water-soluble chitosan in mice10.1016/S0142-9612(98)00159-8 ↗
32. Chitosan as a nonviral gene delivery system. Structure- property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo10.1038/sj.gt.3301492 ↗
33. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation10.1016/j.biomaterials.2006.04.029 ↗
34. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery10.1089/hum.1996.7.12-1437 ↗
35. Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes10.1016/j.jconrel.2005.03.024 ↗
36. Development of a preventive vaccine for Ebola virus infection in primates10.1038/35046108 ↗
37. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates10.1038/nature01876 ↗